Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|April 19, 2018
The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signallingWen-Ze Qiu, Hai-Bo Zhang, Wei-Xiong Xia, et al.
Cancer Communications (London, England)|May 17, 2018
Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysisGuo-Ying Liu, Xing Lv, Yi-Shan Wu, et al.
Therapeutic Advances in Medical Oncology|July 27, 2018
The plasma Epstein-Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic areaHu Liang, Xing Lv, Lin Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2020
MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of itWang-Zhong Li, Guo-Ying Liu, Lan-Feng Lin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2017
Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic areaHu Liang, Yan-Qun Xiang, Xing Lv, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 12, 2024
Anxiety and depression in nasopharyngeal carcinoma patients and network analysis to identify central symptoms: A cross-sectional study from a high-incidence areaZe-Jiang Zhan, Hao-Yang Huang, Yan-Hua Xiao, et al.
Journal of Cancer|September 14, 2018
Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-upQin Yang, Ting-Ting Zhao, Meng-Yun Qiang, et al.
Iscience|December 21, 2023
A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinomaYing-Ying Huang, Yi-Shu Deng, Yang Liu, et al.
The Lancet. Oncology|April 15, 2021
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trialXing Lv, Xun Cao, Wei-Xiong Xia, et al.
Nature Communications|February 10, 2026
Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trialXun Cao, Jia-Yu Zhou, Hao-Yang Huang, et al.
Pageof 4